Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


1 Acta Neurol Scand
1 AJNR Am J Neuroradiol
1 J Neurol
1 J Neurol Neurosurg Psychiatry
5 Mult Scler
2 PLoS One
1 Rev Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Neurol Scand

  1. GAVRILOV YV, Shkilnyuk GG, Valko PO, Stolyarov ID, et al
    Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients.
    Acta Neurol Scand. 2018 Jul 9. doi: 10.1111/ane.12993.
    PubMed     Text format     Abstract available

    AJNR Am J Neuroradiol

  2. FUCHS TA, Carolus K, Benedict RHB, Bergsland N, et al
    Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study.
    AJNR Am J Neuroradiol. 2018 Jul 5. pii: ajnr.A5720. doi: 10.3174/ajnr.A5720.
    PubMed     Text format     Abstract available

    J Neurol

  3. ALADRO Y, Lopez-Alvarez L, Sanchez-Reyes JM, Hernandez-Tamames JA, et al
    Relationship between episodic memory and volume of the brain regions of two functional cortical memory systems in multiple sclerosis.
    J Neurol. 2018 Jul 11. pii: 10.1007/s00415-018-8965.
    PubMed     Text format     Abstract available

    J Neurol Neurosurg Psychiatry

  4. JACOBS BM, Ammoscato F, Giovannoni G, Baker D, et al
    Cladribine: mechanisms and mysteries in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2018 Jul 10. pii: jnnp-2017-317411.
    PubMed     Text format     Abstract available

    Mult Scler

  5. WIJNANDS JM, Zhu F, Kingwell E, Zhao Y, et al
    Five years before multiple sclerosis onset: Phenotyping the prodrome.
    Mult Scler. 2018 Jul 1:1352458518783662. doi: 10.1177/1352458518783662.
    PubMed     Text format     Abstract available

  6. OSHIMA Y, Tanimoto T, Yuji K, Tojo A, et al
    Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
    Mult Scler. 2018 Jul 1:1352458518786075. doi: 10.1177/1352458518786075.
    PubMed     Text format     Abstract available

  7. FISSOLO N, Cervera-Carles L, Villar Guimerans LM, Lleo A, et al
    Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
    Mult Scler. 2018 Jul 1:1352458518786055. doi: 10.1177/1352458518786055.
    PubMed     Text format     Abstract available

  8. SENDERS A, Hanes D, Bourdette D, Carson K, et al
    Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial.
    Mult Scler. 2018 Jul 1:1352458518786650. doi: 10.1177/1352458518786650.
    PubMed     Text format     Abstract available

  9. LIN F, Zivadinov R, Hagemeier J, Weinstock-Guttman B, et al
    Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition.
    Mult Scler. 2018 Jul 1:1352458518788218. doi: 10.1177/1352458518788218.
    PubMed     Text format     Abstract available

    PLoS One

  10. GIOVANNETTI AM, Borreani C, Bianchi E, Giordano A, et al
    Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study.
    PLoS One. 2018;13:e0200532.
    PubMed     Text format     Abstract available

  11. KODA T, Namba A, Nakatsuji Y, Niino M, et al
    Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
    PLoS One. 2018;13:e0193986.
    PubMed     Text format     Abstract available

    Rev Neurol

  12. LABBE T, Ciampi E, Cruz JP, Zurita M, et al
    Functional magnetic resonance imaging in the study of multiple sclerosis.
    Rev Neurol. 2018;67:91-98.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.